Jennifer M. Kirk - 29 Jul 2024 Form 4 Insider Report for Medtronic plc (MDT)

Reporting relationship: Chief Accounting Officer
Issuer ticker: MDT
Reported as of: 29 Jul 2024
Net transaction value: $0
SEC form: 4
Accepted by SEC: 31 Jul 2024, 19:56:09 UTC
Prior SEC filing: 17 Jul 2024
Next SEC filing: 06 Aug 2024
Source filing: View source filing
Reporting owner signature: /s/ Thomas L. Osteraas, attorney-in-fact

Key filing fact

Jennifer M. Kirk filed Form 4 for Medtronic plc (MDT) on 31 Jul 2024.

Key facts

This page summarizes Jennifer M. Kirk's Form 4 filing for Medtronic plc (MDT).
5 reported transactions and 3 derivative rows are listed below.
Accepted by SEC: 31 Jul 2024, 19:56.

Change

Previous filing in this sequence was filed on 17 Jul 2024.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

MDT transaction

Ordinary Shares

Award

Transaction value: $0
Shares: +7,813
Change %: +57%
Price: $0.000000
Shares after: 21,516
Date: 29 Jul 2024
Ownership: Direct
Footnotes: F1, F2

MDT transaction

Ordinary Shares

Award

Transaction value: $0
Shares: +6,326
Change %: +29%
Price: $0.000000
Shares after: 27,842
Date: 29 Jul 2024
Ownership: Direct
Footnotes: F3

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

MDT transaction Derivative

Performance Share Unit

Award

Transaction value: $0
Shares: +7,813
Change %
Price: $0.000000
Shares after: 7,813
Date: 29 Jul 2024
Ownership: Direct
Underlying class: Performance Share Units
Underlying amount: 7,813
Exercise price
Footnotes: F4, F5, F6

MDT transaction Derivative

Performance Share Unit

Award

Transaction value: $0
Shares: +3,125
Change %
Price: $0.000000
Shares after: 3,125
Date: 29 Jul 2024
Ownership: Direct
Underlying class: Performance Share Units
Underlying amount: 3,125
Exercise price
Footnotes: F4, F7

MDT transaction Derivative

Stock Option (Right to Buy)

Award

Transaction value: $0
Shares: +1,540
Change %
Price: $0.000000
Shares after: 1,540
Date: 29 Jul 2024
Ownership: Direct
Underlying class: Ordinary Shares
Underlying amount: 1,540
Exercise price: $80.00
Footnotes: F8

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 8 footnotes

Footnote F1

The restrictions on the award shall lapse 100% on the third anniversary of the Grant Date.

Footnote F2

Includes 196 shares acquired through dividend reinvestment and 299 shares acquired under Medtronic's Employee Stock Ownership Plan since the last report filed by the reporting person.

Footnote F3

Restrictions on the award shall lapse 33% each year following the Grant Date.

Footnote F4

Each performance share unit represents a contingent right to receive one share of Medtronic common stock.

Footnote F5

Vests on July 29, 2027.

Footnote F6

The number of shares to be issued in connection with the performance share units ("PSUs") will vary depending on the level of certain performance metrics achieved over a three (3) year performance period. If target performance metrics are achieved, 7,813 shares will be issued. If maximum performance metrics are achieved, 15,626 shares will be issued. If minimum performance metrics are not met, such PSUs may vest at 0 shares.

Footnote F7

Vests on December 6, 2026.

Footnote F8

These options became exercisable at the rate of 25% of the shares granted per year beginning on the first anniversary of grant.